Is replacing plasma with young donor blood safe for people with mild cognitive impairment?

Replacing a person's blood plasma with plasma from young, healthy donors is an experimental treatment for mild cognitive impairment (MCI). The idea comes from animal studies suggesting that young blood components may rejuvenate the brain. A small pilot study tested this procedure in 12 people with MCI and early Alzheimer's disease. The study focused on safety and feasibility, not on whether the treatment works. So far, the procedure appears safe in the short term, but it is not yet ready for routine use.

What the research says

A pilot study replaced between 16 and 26 liters of blood plasma in 12 people with MCI and biomarker evidence of Alzheimer's disease with plasma from donors aged 18 to 24 ¹. The study tested three different treatment schedules and reported data on safety, feasibility, and patient burden ¹. No serious safety concerns were noted in this small group, but the study was not designed to measure cognitive benefits ¹. The authors emphasize that this was a preliminary safety and feasibility study, and larger, longer trials are needed to determine if the procedure is truly safe and effective ¹. Other sources in the provided set do not address this specific treatment; they cover topics like brain atrophy patterns, nutritional supplements, and cognitive training programs for MCI ^2345678.

What to ask your doctor

• What is the current evidence for plasma exchange or young donor plasma in MCI?
• Are there any ongoing clinical trials for this treatment that I might be eligible for?
• What are the known risks of plasma exchange, such as allergic reactions or infections?
• How does this experimental treatment compare to other options for MCI, like cognitive training or lifestyle changes?
• What should I consider before deciding to participate in a clinical trial for this therapy?